scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1349-7006.2011.01962.X |
P953 | full work available online at | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.2011.01962.x |
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.2011.01962.x | ||
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2011.01962.x | ||
P698 | PubMed publication ID | 21518139 |
P5875 | ResearchGate publication ID | 51075119 |
P50 | author | Masanobu Kano | Q87897587 |
Tomohide Tsukahara | Q88499669 | ||
Makoto Emori | Q89868598 | ||
Toshihiko Torigoe | Q91737677 | ||
Noriyuki Satō | Q113953738 | ||
Toshihiko Yamashita | Q114018411 | ||
Satoshi Kawaguchi | Q114426896 | ||
Masaki Murase | Q114426928 | ||
Takuro Wada | Q59200291 | ||
P2093 | author name string | Noriyuki Sato | |
P2860 | cites work | Strategies of tumor immune evasion | Q22305820 |
Stem cells, cancer, and cancer stem cells | Q27860878 | ||
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis | Q37186425 | ||
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth | Q39703155 | ||
Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas | Q39787753 | ||
Natural killer cells kill human melanoma cells with characteristics of cancer stem cells | Q39843692 | ||
HLA-restricted specific tumor cytolysis by autologous T-lymphocytes infiltrating metastatic bone malignant fibrous histiocytoma of lymph node | Q40328211 | ||
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells | Q42148487 | ||
Malignant fibrous histiocytoma of bone the experience at the Rizzoli Institute: Report of 90 cases | Q44459385 | ||
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. | Q46004947 | ||
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas | Q48381036 | ||
Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study | Q73042273 | ||
Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society | Q73199725 | ||
Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5 | Q80331639 | ||
Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors | Q83603523 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1443-1447 | |
P577 | publication date | 2011-05-31 | |
P1433 | published in | Cancer Science | Q326125 |
P1476 | title | Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma | |
Autologous CTL response against cancer stem‐like cells/cancer‐initiating cells of bone malignant fibrous histiocytoma | |||
P478 | volume | 102 |
Q38502913 | An inhibitor of K+ channels modulates human endometrial tumor-initiating cells. |
Q88647698 | Cancer stem cells: Regulation programs, immunological properties and immunotherapy |
Q26781794 | Immune responses to human cancer stem-like cells/cancer-initiating cells |
Q27014031 | Immunotargeting of cancer stem cells |
Q34196481 | Immunotherapeutic Intervention against Sarcomas |
Q90640291 | Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells |
Q36585140 | Monitoring cancer stem cells: insights into clinical oncology |
Q39099804 | Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells. |
Q38902336 | Peptide vaccination therapy: Towards the next generation |
Q36754981 | Primary malignant fibrous histiocytoma of the breast: report of one case. |
Q55504567 | Researche advances on CIK cells and their clinical use in lung cancer |
Q38829558 | The future of immunotherapy for sarcoma |
Search more.